These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8981964)

  • 1. Insurance underwriting in the genetic era.
    Pokorski RJ
    Am J Hum Genet; 1997 Jan; 60(1):205-16. PubMed ID: 8981964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Underwriting In Long-Term Care Insurance: Market Conditions Limit Options For Higher-Risk Consumers.
    Cornell PY; Grabowski DC; Cohen M; Shi X; Stevenson DG
    Health Aff (Millwood); 2016 Aug; 35(8):1494-503. PubMed ID: 27503976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making the normal deviant: the introduction of predictive medicine in life insurance.
    Van Hoyweghen I; Horstman K; Schepers R
    Soc Sci Med; 2006 Sep; 63(5):1225-35. PubMed ID: 16697510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testing and insurance. The Ad Hoc Committee on Genetic Testing/Insurance Issues.
    Am J Hum Genet; 1995 Jan; 56(1):327-31. PubMed ID: 7825594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of genetic tests and genetic information by life insurance companies: does this differ from the use of routine medical information?
    Zimmerman SE
    Genet Test; 1998; 2(1):3-8. PubMed ID: 10464591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing and genetic discrimination: Public policy when insurance becomes "too expensive".
    Posey LL; Thistle PD
    J Health Econ; 2021 May; 77():102441. PubMed ID: 33676198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurability for asymptomatic hematuria or proteinuria during childhood.
    Feld LG; Stapleton FB
    Am J Kidney Dis; 1993 Aug; 22(2):261-3. PubMed ID: 8352250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insurability and the HIV epidemic: ethical issues in underwriting.
    Daniels N
    Milbank Q; 1990; 68(4):497-525. PubMed ID: 2292989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating genetic discrimination in the Australian life insurance sector: the use of genetic test results in underwriting, 1999-2003.
    Otlowski M; Barlow-Stewart K; Taylor S; Stranger M; Treloar S
    J Law Med; 2007 Feb; 14(3):367-96. PubMed ID: 17355100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol: the Australian genetics and life insurance moratorium-monitoring the effectiveness and response (A-GLIMMER) project.
    Tiller J; McInerney-Leo A; Belcher A; Boughtwood T; Gleeson P; Delatycki M; Barlow-Stewart K; Winship I; Otlowski M; Keogh L; Lacaze P
    BMC Med Ethics; 2021 May; 22(1):63. PubMed ID: 34020638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insurance underwriting in the genetic era.
    Pokorski RJ
    Cancer; 1997 Aug; 80(3 Suppl):587-99. PubMed ID: 11660561
    [No Abstract]   [Full Text] [Related]  

  • 13. The Impact of Policy Incentives on Long-Term Care Insurance and Medicaid Costs: Does Underwriting Matter?
    Cornell PY; Grabowski DC
    Health Serv Res; 2018 Oct; 53(5):3728-3749. PubMed ID: 29770443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of medical directors of life insurance companies concerning use of genetic information.
    McEwen JE; McCarty K; Reilly PR
    Am J Hum Genet; 1993 Jul; 53(1):33-45. PubMed ID: 8317496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age dependent decline of relative risks in life insurance medical underwriting.
    Kneepkens RF; Lindeboom R
    J Insur Med; 2014; 44(3):170-83. PubMed ID: 25622389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
    Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
    Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Genetics is not the issue': insurers on genetics and life insurance.
    Van Hoyweghen I; Horstman K; Schepers R
    New Genet Soc; 2005 Apr; 24(1):79-98. PubMed ID: 16552918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal: a position for the insurance industry on genetic testing.
    Lowden JA
    J Insur Med; 1997; 29(4):260-2. PubMed ID: 10184929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of state insurance commissioners concerning genetic testing and life insurance.
    McEwen JE; McCarty K; Reilly PR
    Am J Hum Genet; 1992 Oct; 51(4):785-92. PubMed ID: 1307229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing and insurance in Australia.
    Otlowski M; Barlow-Stewart K; Lacaze P; Tiller J
    Aust J Gen Pract; 2019 Mar; 48(3):96-99. PubMed ID: 31256467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.